Table 3.
Trials | CFU/spleen |
---|---|
azlocillin–AgNPs conjugate | (29±5)×103 * |
azlocillin and AgNPs combination | (52±17)×106 |
AgNPs | (110±4)×108 |
azlocillin | (89±8)×108 |
normal saline (control) | (200±37)×1010 |
* Indicates a significant difference compared with other groups.